Market Cap
₹3,747 Cr.
P/E
0.00
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
-8.3%
3yr Average
-1.9%
5yr Average
-1.8%
Net Profit Margin
Latest
-15.06%
3yr Average
-3.22%
5yr Average
-3.43%
ROCE
Latest
-4.74%
3yr Average
-0.5%
5yr Average
-1.02%
Debt to Equity
Latest
0.12
3yr Average
0.1
5yr Average
0.09
Market Share
5% (as of Mar 18)
Ampoxin - Market Share
5% (as of Mar 18)
Olsar - Market Share
3% (as of Mar 18)
Telsar - Market Share
16% (as of Mar 18)
Unienzyme - Market Share
6% (as of Mar 18)
Vizlac - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis